Chlamydia and Mycoplasma Objectives

Total Page:16

File Type:pdf, Size:1020Kb

Chlamydia and Mycoplasma Objectives Chlamydia and Mycoplasma Objectives • To know about Chlamydia and Mycoplasma ✓Classification ✓Morphology ✓Diseases ✓Lab diagnosis Classification • Family - Chlamydiacae. • Two genus – Chlamydia and Chlamydophila.. • Has three important human pathogens – C . trachomatis. – Chlamydophila psittaci – Chlamydophila pneumoniae Chlamydiacae • Family Chlamydiacae are obligate intracellular bacterial parasites. • They have tropism for squamous epithelial and macrophages of the respiratory tract and GUT. • Depend for energy on host cell . General features • Smallest prokayotic cell . • Round to ovoid. • Two lipid bilayers resembling a gram negative envelope. • Non motile. • Gram negative. • Possess both DNA and RNA and ribosome . • Differ from other bacteria - No Peptidoglycan content in their cell wall. Lack enzymes of ETC. Require ATP and nutrient sources from host cells. Morpholology and growth Chlamydia replicate by unique complex cycle in susceptible host cell - They exist in two morphological forms • Elementary body- extracellular , infectious form, spherical, rigid cellwall • Reticulate body – intracellular, growing , replicative form,oval pliable cell wall, Replicative cycle • EB attach to surface – engulfed by cell – Form phagosome – after 6-8 hrs reorganise into RB and replication continues for 18 - 24 hrs. Inclusion body – intracytoplasmic vacuole filled with RB. Can be detected by histologic stains. After 48 hrs – multiplication stops and change to EBs. By 72 hrs – host cell rupture releasing infected EBs. Resistance • Being heat labile Inactivated at 56 deg within minutes. – Susceptible to chemicals like ether ,ethanol formalin . – Can be stocked at 4 deg C. – Culture can be preserved frozen at -70 deg. Antigenic structure • Two major antigens - Genus specific – lipopolysaccharide.(3-deoxy- manno-octulosonic acid). Important in scarring and fibrosis by inducing cytokines. Antibodies can be detected by IF and CF tests. Species specific- outer membrane proteins . – Elicits protective immunity. – IF Serotype specific - serovars on basis of MOMP. Serological typing • Chlamydia- 3 species C.trachomatis, C.suis , C. muridarum C.trachomatis divided into biovars TRIC- trachoma inclusion conjunctivitis LGV - lymphogranuloma venerum BIOVARS are further divided into many serotypes . Chlamydophila Has 6 species- • C.pneumonia- no biovars ,no serotypes. • C.psittaci -no biovars ,many serotypes • C.pecorum • C.caviae • C.felis • C.abortus DISEASES • C.trachomatis – genitourinary infection and eye infection. • C.psittaci – respiratory infection. • C. pneumoniae – atypical pneumonia. Laboratory diagnosis • Specimens- depend on type of lesion (urethra cervix,conjunctiva, lung) –scraping , swabs, blood. • Cytological examination. • Culture and isolation- cell culture/ yolk sac / mice • Detection of chlamydia antigen - Direct Fluoroscent antiody/Elisa • Serodiagnosis - microimmunofluorescence Chlamydia trachomatis • Trachoma – keratoconjunctivitis. (A,B,Ba,and C. ) Conjunctival scraping- inclusion bodies known as Helberstaedter- prowazek body • Lymphogranuloma venerum • Inclusion conjunctivitis in adults • Non gonococcal urethritis • Perinatal infections • Neonatal conjunctivitis • Infant pneumonia LGV • Sexually transmitted disease characterised by suppurative inguinal adenitis . • C. trachomatis serovars L1,L2 and L3. INCLUSION CONJUNCTIVITIS Sexually active adults it may transfer to eye through genital secretions and lead to paratrachoma and is caused by D to K also known as swimming pool conjunctivitis. Non gonococcal urethritis • Caused by serotypes D-K. • Inflammation of genital organs. • Perinatal infection Neonatal conjunctivitis Infant pneumonia Laboratory diagnosis • Smears- inclusion body by Giemsa. • Isolation- cell culture HeLa Cells ,McCoy and BHK. • Antigen detection-DirectFluoroscent antibody/ Elisa . • Nucleic acid probe/PCR/LCR. • Serological test –CFT and micro IF. Treatment • Sulphonamide and Tetracycline. Chlamydophila pneumoniae • Clinical findings- bronchitis and pneumonia,pharyngitis ,coronary heart disease, asthma. • Laboratory diagnosis – same. - demonstration of elimentary bodies. - culture. - antigen , antibodies detection. • Treatment- macrolides. Chlamydia psittaci • Source – infected birds . • Clinical presentation – influenza like syndrome ,pneumonia. • Epidemiology – occupational. • Lab diagnosis – culture – levinthal colelillie bodies. • Antigen detection –DIF , EIA • Treatment- tetracycline ,macrolide. Mycoplasma • Smallest free living bacteria ,pass bacterial filter. Morphology – gram negative ,pleomorphic. Also known as PPLO (pleuropneumonia like organism ) • Lack cell wall . • Enclosed in trilayered membrane having sterol . Reproduction • Divide by binary fission. • Grow on cell free media. • Adhere to epithelium of respiratory and urogenital tract. Classification • Mycoplasmatacae Mycoplasma do not hydrolyse urea. Ureaplasma hydrolyse urea. • Pathogenic to humans M.hominis M.pneumoniae U.urealyticum Cultivation • Facultatively anareobic. • For primary isolation 95 %nitrogen and 5% CO2 • 22-41 deg c. • Media – enriched with 20 percent horse serum and yeast extract. • PPLO broth -yeast extract , serum, glucose ,phenol red. • Solidified by agar , SP-4 media , Mycotrin RS. • Fried egg colony . • Seen by Dienes method Biochemical reaction • Mycoplasma – mostly fermentative. • Urea – hydrolysed by ureaplasma. • Not proteolytic. Resistance • Heating at 56 deg for 30 min. • Resistant to pencillin and cephalosporin. • Resistant to UV light . • Sensitive to tetracycline, cholorohxidine and cetrimide. • Lyophilization / freezing broth cultures at -70 deg. Antigenic structure • Cell membrane constituents - glycolipids act as antigen in vitro in CFT. - protein -P1. Antibodies are found in convalescent serum and respiratory secretion. M. pneumoniae • Mild URTI. • LRTI. • Tracheobronchitis and pneumonia (primary atypical pneumonia or walking pneumonia ) • School age children and young adults. • Complications may occur M. genitalium • Non gonococcal urethritis and PID . • U. urealyticum causes genital infection. • Transmitted by sexual contact. • M. hominis – lower genital tract. • Cause non gonococcal urethritis . Laboratory diagnosis • Specimen – depends on lesion . • Culture –PPLO medium . • Isolation and identification • Colonies- mulberry shaped /fried egg • Species identification Haemadsorption test(G.pig RBC adheres to colonies of M.pneum and not hominis ) • Tetrazolium reduction test- M.pneumoniae appear red. • Serological technique-ELISA and IFA • PCR and DNA probes – high sensitivity Antigen detection – IF , EIA ,IMMUNOBLOTTING DNA probes – 16SrRNA sequence in resp. exudate. Serological tests Specific test using mycoplasmal antigens - CFT - ELISA Non specific test Streptococcus MG test- unheated serum and heat killed str. MG suspension Cold Agglutination TEST-antibodies that bind to human erythrocytes at low temp 4 deg Treatment • Tetracycline. • Macrolides (azithromycin ). • Fluoroquinolones. Further reading • Essentials of medical microbiology. Apurba S Sastry. • Textbook of Microbiology . Ananthannarayan and Paniker. Mcqs 1. All of the following are true except a. Elementary body is metablically active b. Reticulate body is the replicating form c. Reticulate body is intracellular form d. Elementary body is infectious form 2 . The most commonly used method for isolation of Chlamydia: a. Culture on artificial media b. Culture on Vero cell line c. Inoculation into guinea pig d. Culture on McCoy cell line 3. The most sensitive and specific test for Chlamydia diagnosis: a. Direct immunofluorescence test (DIF) b. Culture on McCoy cell line c. Nucleic acid amplification tests (NAAT) d. Micro-immunofluorescence (MIF) test 4. Which is not a property of Mycoplasma? a. Susceptibility to beta lactams b. Have both DNA and RNA c. Mycoplasmo pneumonioe d. Streptococcus pneumoniae 5. Fried egg colonies are produced by: a. Bacillus cereus b. Haemophilus influenzae c. Neisseria subflavo d. Mycoplosma pneumoniae .
Recommended publications
  • Bacterial Communities of the Upper Respiratory Tract of Turkeys
    www.nature.com/scientificreports OPEN Bacterial communities of the upper respiratory tract of turkeys Olimpia Kursa1*, Grzegorz Tomczyk1, Anna Sawicka‑Durkalec1, Aleksandra Giza2 & Magdalena Słomiany‑Szwarc2 The respiratory tracts of turkeys play important roles in the overall health and performance of the birds. Understanding the bacterial communities present in the respiratory tracts of turkeys can be helpful to better understand the interactions between commensal or symbiotic microorganisms and other pathogenic bacteria or viral infections. The aim of this study was the characterization of the bacterial communities of upper respiratory tracks in commercial turkeys using NGS sequencing by the amplifcation of 16S rRNA gene with primers designed for hypervariable regions V3 and V4 (MiSeq, Illumina). From 10 phyla identifed in upper respiratory tract in turkeys, the most dominated phyla were Firmicutes and Proteobacteria. Diferences in composition of bacterial diversity were found at the family and genus level. At the genus level, the turkey sequences present in respiratory tract represent 144 established bacteria. Several respiratory pathogens that contribute to the development of infections in the respiratory system of birds were identifed, including the presence of Ornithobacterium and Mycoplasma OTUs. These results obtained in this study supply information about bacterial composition and diversity of the turkey upper respiratory tract. Knowledge about bacteria present in the respiratory tract and the roles they can play in infections can be useful in controlling, diagnosing and treating commercial turkey focks. Next-generation sequencing has resulted in a marked increase in culture-independent studies characterizing the microbiome of humans and animals1–6. Much of these works have been focused on the gut microbiome of humans and other production animals 7–11.
    [Show full text]
  • Compendium of Measures to Control Chlamydia Psittaci Infection Among
    Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017 Author(s): Gary Balsamo, DVM, MPH&TMCo-chair Angela M. Maxted, DVM, MS, PhD, Dipl ACVPM Joanne W. Midla, VMD, MPH, Dipl ACVPM Julia M. Murphy, DVM, MS, Dipl ACVPMCo-chair Ron Wohrle, DVM Thomas M. Edling, DVM, MSpVM, MPH (Pet Industry Joint Advisory Council) Pilar H. Fish, DVM (American Association of Zoo Veterinarians) Keven Flammer, DVM, Dipl ABVP (Avian) (Association of Avian Veterinarians) Denise Hyde, PharmD, RP Preeta K. Kutty, MD, MPH Miwako Kobayashi, MD, MPH Bettina Helm, DVM, MPH Brit Oiulfstad, DVM, MPH (Council of State and Territorial Epidemiologists) Branson W. Ritchie, DVM, MS, PhD, Dipl ABVP, Dipl ECZM (Avian) Mary Grace Stobierski, DVM, MPH, Dipl ACVPM (American Veterinary Medical Association Council on Public Health and Regulatory Veterinary Medicine) Karen Ehnert, and DVM, MPVM, Dipl ACVPM (American Veterinary Medical Association Council on Public Health and Regulatory Veterinary Medicine) Thomas N. Tully JrDVM, MS, Dipl ABVP (Avian), Dipl ECZM (Avian) (Association of Avian Veterinarians) Source: Journal of Avian Medicine and Surgery, 31(3):262-282. Published By: Association of Avian Veterinarians https://doi.org/10.1647/217-265 URL: http://www.bioone.org/doi/full/10.1647/217-265 BioOne (www.bioone.org) is a nonprofit, online aggregation of core research in the biological, ecological, and environmental sciences. BioOne provides a sustainable online platform for over 170 journals and books published by nonprofit societies, associations, museums, institutions, and presses. Your use of this PDF, the BioOne Web site, and all posted and associated content indicates your acceptance of BioOne’s Terms of Use, available at www.bioone.org/page/terms_of_use.
    [Show full text]
  • Table S4. Phylogenetic Distribution of Bacterial and Archaea Genomes in Groups A, B, C, D, and X
    Table S4. Phylogenetic distribution of bacterial and archaea genomes in groups A, B, C, D, and X. Group A a: Total number of genomes in the taxon b: Number of group A genomes in the taxon c: Percentage of group A genomes in the taxon a b c cellular organisms 5007 2974 59.4 |__ Bacteria 4769 2935 61.5 | |__ Proteobacteria 1854 1570 84.7 | | |__ Gammaproteobacteria 711 631 88.7 | | | |__ Enterobacterales 112 97 86.6 | | | | |__ Enterobacteriaceae 41 32 78.0 | | | | | |__ unclassified Enterobacteriaceae 13 7 53.8 | | | | |__ Erwiniaceae 30 28 93.3 | | | | | |__ Erwinia 10 10 100.0 | | | | | |__ Buchnera 8 8 100.0 | | | | | | |__ Buchnera aphidicola 8 8 100.0 | | | | | |__ Pantoea 8 8 100.0 | | | | |__ Yersiniaceae 14 14 100.0 | | | | | |__ Serratia 8 8 100.0 | | | | |__ Morganellaceae 13 10 76.9 | | | | |__ Pectobacteriaceae 8 8 100.0 | | | |__ Alteromonadales 94 94 100.0 | | | | |__ Alteromonadaceae 34 34 100.0 | | | | | |__ Marinobacter 12 12 100.0 | | | | |__ Shewanellaceae 17 17 100.0 | | | | | |__ Shewanella 17 17 100.0 | | | | |__ Pseudoalteromonadaceae 16 16 100.0 | | | | | |__ Pseudoalteromonas 15 15 100.0 | | | | |__ Idiomarinaceae 9 9 100.0 | | | | | |__ Idiomarina 9 9 100.0 | | | | |__ Colwelliaceae 6 6 100.0 | | | |__ Pseudomonadales 81 81 100.0 | | | | |__ Moraxellaceae 41 41 100.0 | | | | | |__ Acinetobacter 25 25 100.0 | | | | | |__ Psychrobacter 8 8 100.0 | | | | | |__ Moraxella 6 6 100.0 | | | | |__ Pseudomonadaceae 40 40 100.0 | | | | | |__ Pseudomonas 38 38 100.0 | | | |__ Oceanospirillales 73 72 98.6 | | | | |__ Oceanospirillaceae
    [Show full text]
  • Ehrlichiosis in Brazil
    Review Article Rev. Bras. Parasitol. Vet., Jaboticabal, v. 20, n. 1, p. 1-12, jan.-mar. 2011 ISSN 0103-846X (impresso) / ISSN 1984-2961 (eletrônico) Ehrlichiosis in Brazil Erliquiose no Brasil Rafael Felipe da Costa Vieira1; Alexander Welker Biondo2,3; Ana Marcia Sá Guimarães4; Andrea Pires dos Santos4; Rodrigo Pires dos Santos5; Leonardo Hermes Dutra1; Pedro Paulo Vissotto de Paiva Diniz6; Helio Autran de Morais7; Joanne Belle Messick4; Marcelo Bahia Labruna8; Odilon Vidotto1* 1Departamento de Medicina Veterinária Preventiva, Universidade Estadual de Londrina – UEL 2Departamento de Medicina Veterinária, Universidade Federal do Paraná – UFPR 3Department of Veterinary Pathobiology, University of Illinois 4Department of Veterinary Comparative Pathobiology, Purdue University, Lafayette 5Seção de Doenças Infecciosas, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul – UFRGS 6College of Veterinary Medicine, Western University of Health Sciences 7Department of Clinical Sciences, Oregon State University 8Departamento de Medicina Veterinária Preventiva e Saúde Animal, Universidade de São Paulo – USP Received June 21, 2010 Accepted November 3, 2010 Abstract Ehrlichiosis is a disease caused by rickettsial organisms belonging to the genus Ehrlichia. In Brazil, molecular and serological studies have evaluated the occurrence of Ehrlichia species in dogs, cats, wild animals and humans. Ehrlichia canis is the main species found in dogs in Brazil, although E. ewingii infection has been recently suspected in five dogs. Ehrlichia chaffeensis DNA has been detected and characterized in mash deer, whereas E. muris and E. ruminantium have not yet been identified in Brazil. Canine monocytic ehrlichiosis caused by E. canis appears to be highly endemic in several regions of Brazil, however prevalence data are not available for several regions.
    [Show full text]
  • Sexually Transmitted Infections: Diagnosis and Management
    SEXUALLY TRANSMITTED INFECTIONS: DIAGNOSIS AND MANAGEMENT STEPHANIE N. TAYLOR, MD LSUHSC SECTION OF INFECTIOUS DISEASES MEDICAL DIRECTOR, DELGADO CENTER PERSONAL HEALTH CENTER NEW ORLEANS, LA INTRODUCTION Ê Tremendous Public Health Problem Ê AtitdAn estimated 15 m illion AiAmericans acqu ire an STD each year Ê $10 billion dollars in healthcare costs per year Ê Substantial morbidity/mortality Ê Ulcerative and non-ulcerative STDs associated with increased HIV transmission STI PRINCIPLES Ê Counseling – HIV infection, abstinence, and “safer sex” practices Ê STD Screening of asymptomatic individuals and those with symptoms Ê Patients with one STD often have another Ê Partners should be evaluated and treated empirically at the time of presentation STI PRINCIPLES Ê Serologic testing for syphilis should be done in all patients Ê HIV t esti ng sh ould be s trong ly encouraged in all patients (New CDC Recommendation for “Opt-Out” testing) Ê STDs are associated with HIV transmission Major STI Pathogens Ê Bacteria Ê Viruses Ê HSV I & II, HPV, Ê Neisseria HBV, HIV , gonorrhoeae, molluscum Haemophilus ducreyi, Ê Protozoa GdGardnere lla vag inali s Ê Trichomonas Ê Spirochetes vaginalis Ê Fungi Ê Treponema pa llidum Ê Candida albicans Ê Chlamydia Ê Ectoparasites Ê Chlamy dia Ê Phthiris pubis, trachomatis Sarcoptes scabei MAJOR STI SYNDROMES Ê GENITAL ULCER DISEASE Ê URETHRITIS/CERVICITIS Ê PELVIC INFLAMMATORY DISEASE Ê VAGINITIS Ê OTHER VIRAL STDs Ê ECTOPARASITES GENITAL ULCER DISEASE Differential Diagnosis: Ê STIs Ê Syphilis, Herpes, Chancroid Ê LGV,
    [Show full text]
  • Chlamydia Trachomatis and Chlamydia Pneumoniae Interaction with the Host: Latest Advances and Future Prospective
    microorganisms Review Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective Marisa Di Pietro 1,* , Simone Filardo 1 , Silvio Romano 2 and Rosa Sessa 1 1 Department of Public Health and Infectious Diseases, Section of Microbiology, University of Rome “Sapienza”, 00185 Rome, Italy; simone.fi[email protected] (S.F.); [email protected] (R.S.) 2 Cardiology, Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy; [email protected] * Correspondence: [email protected] Received: 15 April 2019; Accepted: 14 May 2019; Published: 16 May 2019 Abstract: Research in Chlamydia trachomatis and Chlamydia pneumoniae has gained new traction due to recent advances in molecular biology, namely the widespread use of the metagenomic analysis and the development of a stable genomic transformation system, resulting in a better understanding of Chlamydia pathogenesis. C. trachomatis, the leading cause of bacterial sexually transmitted diseases, is responsible of cervicitis and urethritis, and C. pneumoniae, a widespread respiratory pathogen, has long been associated with several chronic inflammatory diseases with great impact on public health. The present review summarizes the current evidence regarding the complex interplay between C. trachomatis and host defense factors in the genital micro-environment as well as the key findings in chronic inflammatory diseases associated to C. pneumoniae. Keywords: Chlamydia trachomatis; Chlamydia pneumoniae; host-pathogen interaction 1. Introduction Currently, there is a renewed research interest in Chlamydiae that cause a broad spectrum of pathologies of varying severity in human, mainly Chlamydia trachomatis and Chlamydia pneumoniae [1,2]. Advances in molecular biology and, in particular, the recent advent of metagenomic analysis as well as the development of a stable genomic transformation system in Chlamydiae have significantly contributed to expanding our understanding of Chlamydia pathogenesis [3–5].
    [Show full text]
  • Tick-Borne Disease Working Group 2020 Report to Congress
    2nd Report Supported by the U.S. Department of Health and Human Services • Office of the Assistant Secretary for Health Tick-Borne Disease Working Group 2020 Report to Congress Information and opinions in this report do not necessarily reflect the opinions of each member of the Working Group, the U.S. Department of Health and Human Services, or any other component of the Federal government. Table of Contents Executive Summary . .1 Chapter 4: Clinical Manifestations, Appendices . 114 Diagnosis, and Diagnostics . 28 Chapter 1: Background . 4 Appendix A. Tick-Borne Disease Congressional Action ................. 8 Chapter 5: Causes, Pathogenesis, Working Group .....................114 and Pathophysiology . 44 The Tick-Borne Disease Working Group . 8 Appendix B. Tick-Borne Disease Working Chapter 6: Treatment . 51 Group Subcommittees ...............117 Second Report: Focus and Structure . 8 Chapter 7: Clinician and Public Appendix C. Acronyms and Abbreviations 126 Chapter 2: Methods of the Education, Patient Access Working Group . .10 to Care . 59 Appendix D. 21st Century Cures Act ...128 Topic Development Briefs ............ 10 Chapter 8: Epidemiology and Appendix E. Working Group Charter. .131 Surveillance . 84 Subcommittees ..................... 10 Chapter 9: Federal Inventory . 93 Appendix F. Federal Inventory Survey . 136 Federal Inventory ....................11 Chapter 10: Public Input . 98 Appendix G. References .............149 Minority Responses ................. 13 Chapter 11: Looking Forward . .103 Chapter 3: Tick Biology, Conclusion . 112 Ecology, and Control . .14 Contributions U.S. Department of Health and Human Services James J. Berger, MS, MT(ASCP), SBB B. Kaye Hayes, MPA Working Group Members David Hughes Walker, MD (Co-Chair) Adalbeto Pérez de León, DVM, MS, PhD Leigh Ann Soltysiak, MS (Co-Chair) Kevin R.
    [Show full text]
  • Sexually Transmitted Infections Treatment Guidelines, 2021
    Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 70 / No. 4 July 23, 2021 Sexually Transmitted Infections Treatment Guidelines, 2021 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS Introduction ............................................................................................................1 Methods ....................................................................................................................1 Clinical Prevention Guidance ............................................................................2 STI Detection Among Special Populations ............................................... 11 HIV Infection ......................................................................................................... 24 Diseases Characterized by Genital, Anal, or Perianal Ulcers ............... 27 Syphilis ................................................................................................................... 39 Management of Persons Who Have a History of Penicillin Allergy .. 56 Diseases Characterized by Urethritis and Cervicitis ............................... 60 Chlamydial Infections ....................................................................................... 65 Gonococcal Infections ...................................................................................... 71 Mycoplasma genitalium .................................................................................... 80 Diseases Characterized
    [Show full text]
  • Human Anaplasmosis and Anaplasma Ovis Variant
    LETTERS Human teria. A chest radiograph, computed ware (www.ebi.ac.uk/Tools/clustalw2/ tomography of the abdomen, and an index.html) and the GenBank/Europe- Anaplasmosis and echocardiograph of the heart showed an Molecular Biology database library Anaplasma ovis unremarkable results. Blood samples (http://blast.ncbi.nlm.nih.gov/Blast. Variant were negative for antibodies against cgi). Phylogenetic trees were con- cytomegalovirus, Epstein-Barr virus, structed by using MEGA 4 software To the Editor: Anaplasmosis is a hepatitis, HIV, mycoplasma, coxackie (www.megasoftware.net). disease caused by bacteria of the genus virus, adenovirus, parvovirus, Cox- The fi rst blood sample was posi- Anaplasma. A. marginale, A. centrale, iella burnetii, R. conorii, and R. typhi, tive for A. ovis by PCR; the other 2 A. phagocytophilum, A. ovis, A. bovis, and for rheumatoid factors. A lymph were negative. A 16S rRNA gene se- and A. platys are obligate intracellular node biopsy specimen was negative quence (EU448141) from the posi- bacteria that infect vertebrate and in- for infi ltration and malignancy. After tive sample showed 100% similarity vertebrate host cells. A. ovis, which is treatment with doxycycline (200 mg/ with other Anaplasma spp. sequences transmitted primarily by Rhipicepha- day for 11 days), ceftriaxone (2 g/day (A. marginale, A. centrale, A. ovis) lus bursa ticks, is an intraerythrocytic for 5 days), and imipenem/cilastatin in GenBank. Anaplasma sp. groEL rickettsial pathogen of sheep, goats, (1,500 mg/day for 1 day), the patient and msp4 genes showed a 1,650-bp and wild ruminants (1). recovered and was discharged 17 days sequence (FJ477840, corresponding Anaplasma spp.
    [Show full text]
  • Genetic Diversity in Treponema Pallidum: Implications for Pathogenesis, Evolution and Molecular Diagnostics of Syphilis and Yaws ⇑ David Šmajs A, , Steven J
    Infection, Genetics and Evolution 12 (2012) 191–202 Contents lists available at SciVerse ScienceDirect Infection, Genetics and Evolution journal homepage: www.elsevier.com/locate/meegid Review Genetic diversity in Treponema pallidum: Implications for pathogenesis, evolution and molecular diagnostics of syphilis and yaws ⇑ David Šmajs a, , Steven J. Norris b, George M. Weinstock c a Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00 Brno, Czech Republic b Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, 6431 Fannin Street, Houston, TX 77030, USA c The Genome Institute, Washington University, 4444 Forest Park Avenue, Campus Box 8501, St. Louis, MO 63108, USA article info abstract Article history: Pathogenic uncultivable treponemes, similar to syphilis-causing Treponema pallidum subspecies pallidum, Received 21 September 2011 include T. pallidum ssp. pertenue, T. pallidum ssp. endemicum and Treponema carateum, which cause yaws, Received in revised form 5 December 2011 bejel and pinta, respectively. Genetic analyses of these pathogens revealed striking similarity among Accepted 7 December 2011 these bacteria and also a high degree of similarity to the rabbit pathogen, Treponema paraluiscuniculi,a Available online 15 December 2011 treponeme not infectious to humans. Genome comparisons between pallidum and non-pallidum trepo- nemes revealed genes with potential involvement in human infectivity, whereas comparisons between Keywords: pallidum and pertenue treponemes identified genes possibly involved in the high invasivity of syphilis Treponema pallidum treponemes. Genetic variability within syphilis strains is considered as the basis of syphilis molecular Treponema pallidum ssp. pertenue Treponema pallidum ssp. endemicum epidemiology with potential to detect more virulent strains, whereas genetic variability within a single Treponema paraluiscuniculi strain is related to its ability to elude the immune system of the host.
    [Show full text]
  • Sexually Transmitted Diseases Treatment Guidelines, 2015
    Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS CONTENTS (Continued) Introduction ............................................................................................................1 Gonococcal Infections ...................................................................................... 60 Methods ....................................................................................................................1 Diseases Characterized by Vaginal Discharge .......................................... 69 Clinical Prevention Guidance ............................................................................2 Bacterial Vaginosis .......................................................................................... 69 Special Populations ..............................................................................................9 Trichomoniasis ................................................................................................. 72 Emerging Issues .................................................................................................. 17 Vulvovaginal Candidiasis ............................................................................. 75 Hepatitis C ......................................................................................................... 17 Pelvic Inflammatory
    [Show full text]
  • Mycoplasma Is an Overlooked Lyme Co-Infection Got a Question? (Comments Are Moderated & Won't Immediately Appear)
    Mycoplasma Is An Overlooked Lyme Co-Infection Got A Question? (comments are moderated & won't immediately appear) February 23, 2011 Getting Lyme Mycoplasma infections are commonly found in people with Lyme Disease. But most doctors don’t know to test for them. These are the smallest organisms that can live independently. Of the over 100 known species, more than a dozen are found in humans. Many of them cause disease. They don’t have a cell wall or cell nucleus, usually act like parasites within or outside host cells, and can take on different shapes. This versatility allows them to hide from the immune system and affect it in many ways. Because of these features, they are hard to diagnose and treat. Mycoplasma Pneumoniae The most common specie typically causes respiratory infections like pneumonia, bronchitis, pharyngitis, and asthma. But it’s a stealth pathogen that can also cause non-respiratory diseases affecting the nervous system, blood, joints, skin, heart, liver, and pancreas. Estimates of Mycoplasma pneumoniae cases each year in the United States are typically as high as two million. The disease tends to be cyclical both within a given year and across a decade. Most cases appear in the late summer and early fall with sharp spikes every three to five years. The disease spreads quickly from person to person by tiny droplets expelled during a cough. Other Mycoplasma Species The other pathogenic species most typically found in humans are: o M. fermentans o M. genitalium o M. hominis o M. pirum o M. salivarium o Ureaplasma urealyticum o Ureaplasma parvum Symptoms Mycoplasma pneumoniae likes to live on the surface cells (mucosa) of the respiratory tract and can cause inflammation of most structures there.
    [Show full text]